Live Status Check

NCT06302621 Recruiting Status

Real-time enrollment status for this advanced solid tumor clinical trial

Current Status

Recruiting

Auto-verified from ClinicalTrials.gov

Checked: July 13, 2026 at 4:17 PM UTC

NCT06302621 Status Summary

NCT NumberNCT06302621
Recruiting StatusRecruiting
ConditionAdvanced Solid Tumor
PhaseClinical Trial
Target Enrollment70 participants
Active Locations1 sites in the US
SponsorMassachusetts General Hospital
Last Updated on CT.govMay 15, 2026 (May 15, 2026)

About NCT06302621 Enrollment Status

As of July 13, 2026: Clinical trial NCT06302621 is currently recruiting participants. This clinical trial study for advanced solid tumor is actively seeking new participants at 1 location across the United States. The study is sponsored by Massachusetts General Hospital. This status information is automatically verified from the official ClinicalTrials.gov registry.

Frequently Asked Questions About NCT06302621

Is NCT06302621 still recruiting?

Yes, NCT06302621 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.

Where is NCT06302621 recruiting?

This trial is recruiting at 1 location in the United States. View all available locations on the full study page.

How do I enroll in NCT06302621?

Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.

When was NCT06302621 status last updated?

The official ClinicalTrials.gov record for NCT06302621 was last updated May 15, 2026 (May 15, 2026). HelloStudys verifies this status automatically.

Ready to Apply?

Check your eligibility for this clinical trial